Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01154374 · ClinicalTrials.gov registry record · Phase 2
A Clinical Study of the Safety and Efficacy of MEBO® Wound Ointment in Subjects With Diabetic Foot Ulcers (Pilot)
A Phase 2 study, sponsored by Skingenix.
- Completed
- Registry status
- Phase 2
- Development phase
- 7
- Enrollment target
NCT01154374 is a Phase 2 study that has completed, run by Skingenix. The registered enrollment target is 7 participants.
The verdict
NCT01154374, a Phase 2 study, has completed, sponsored by Skingenix.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 7 participants
- Enrollment target
Study Summary
The objective of this study is to evaluate the safety and efficacy of MEBO in the treatment of subjects with diabetic foot ulcers (DFUs).
Interventions
- DRUG MEBO Wound Ointment
- PROCEDURE Standard of Care (sterile saline moistened gauze)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2010-11 |
| Est. Completion | 2011-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01154374
The ClinicalTrials.gov registry entry for NCT01154374 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Skingenix, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which MEBO Wound Ointment is the first listed.
NCT01154374 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01154374 about?
NCT01154374 is a clinical study titled "A Clinical Study of the Safety and Efficacy of MEBO® Wound Ointment in Subjects With Diabetic Foot Ulcers (Pilot)". The objective of this study is to evaluate the safety and efficacy of MEBO in the treatment of subjects with diabetic foot ulcers (DFUs).
What is the current status of trial NCT01154374?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 7 participants. The study started on 2010-11. Estimated completion is 2011-10.
What interventions are being tested in trial NCT01154374?
The interventions under investigation include: MEBO Wound Ointment (DRUG), Standard of Care (sterile saline moistened gauze) (PROCEDURE).
Who is sponsoring clinical trial NCT01154374?
This trial is sponsored by Skingenix, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.